| TA125 |
Psoriatic arthritis (moderate to severe) - adalimumab (TA125) (replaced by TA199) |
|
-
-
Adalimumab for the treatment of psoriatic arthritis
This guidance has been replaced by TA199 Psoriatic arthritis - etanercept, infliximab and adalimumab
-
Other information
How this guidance was produced
Background information
- None found
This page was last updated: 20 December 2011
-
-
Guidance formats
-
Implementation tools and resources
- None available
See this guidance in practice
Patient
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
NICE Guidance
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
Full Guidance
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.
